{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,4]],"date-time":"2026-08-04T10:51:39Z","timestamp":1785840699131,"version":"3.56.0"},"reference-count":47,"publisher":"Wiley","license":[{"start":{"date-parts":[[2026,8,4]],"date-time":"2026-08-04T00:00:00Z","timestamp":1785801600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"},{"start":{"date-parts":[[2026,8,4]],"date-time":"2026-08-04T00:00:00Z","timestamp":1785801600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/doi.wiley.com\/10.1002\/tdm_license_1.1"}],"content-domain":{"domain":["onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":["J of Diabetes Invest"],"abstract":"<jats:title>ABSTRACT<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Objectives<\/jats:title>\n                    <jats:p>We aimed to identify microribonucleic acids (miRNAs) that could serve as biomarkers for slowly progressive type 1 diabetes mellitus (SPIDDM).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Materials and Methods<\/jats:title>\n                    <jats:p>\n                      We conducted a retrospective study of adult patients with SPIDDM who fulfilled the criteria for SPIDDM (definite) (\n                      <jats:italic>n<\/jats:italic>\n                      \u2009=\u200960), type 2 diabetes mellitus (T2DM) (\n                      <jats:italic>n<\/jats:italic>\n                      \u2009=\u200959), and healthy controls (\n                      <jats:italic>n<\/jats:italic>\n                      \u2009=\u200950) to analyze the serum expression levels of 40 miRNAs reported to be altered in latent autoimmune diabetes in adults and type 1 diabetes using quantitative real\u2010time polymerase chain reaction, specifically analyzing serum collected at the time of diagnosis as SPIDDM (probable) in the SPIDDM group. For miRNAs showing significant differences between the groups, we performed logistic regression analysis. In the SPIDDM group, we performed linear regression analysis on miRNAs correlated with the C\u2010peptide index (CPI) at the last outpatient visit as identified by Spearman's rank correlation.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>The serum expression levels of miR\u2010143\u20103p, miR\u201021\u20105p, miR\u2010223\u20103p, and miR\u2010517b\u20103p differed significantly in the SPIDDM group compared with the type 2 diabetes mellitus and control groups. Multivariate logistic regression analysis distinguishing SPIDDM from type 2 diabetes mellitus revealed miR\u201021\u20105p, miR\u2010223\u20103p, and miR\u2010517b\u20103p as independent discriminators. Correlation and multivariate linear regression analyses revealed that miR\u2010150\u20105p was selected as an independent predictor of CPI at the last outpatient visit.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>This study identified serum miRNAs as potential biomarkers in adult patients with SPIDDM, particularly miR\u2010150\u20105p as a candidate marker for predicting subsequent decline in insulin secretion.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1111\/jdi.70402","type":"journal-article","created":{"date-parts":[[2026,8,4]],"date-time":"2026-08-04T10:27:51Z","timestamp":1785839271000},"update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Serum\u2010derived microribonucleic acids as potential novel biomarkers for slowly progressive type 1 diabetes mellitus"],"prefix":"10.1111","author":[{"ORCID":"https:\/\/orcid.org\/0009-0009-3194-4286","authenticated-orcid":false,"given":"Hideyuki","family":"Okuma","sequence":"first","affiliation":[{"name":"Department of Diabetes and Endocrinology, Graduate School of Interdisciplinary Research, Faculty of Medicine University of Yamanashi  Yamanashi Japan"},{"name":"Department of Diabetes and Endocrinology Nerima Hikarigaoka Hospital  Tokyo Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0007-9724-3357","authenticated-orcid":false,"given":"Takahiro","family":"Tsutsumi","sequence":"additional","affiliation":[{"name":"Department of Diabetes and Endocrinology, Graduate School of Interdisciplinary Research, Faculty of Medicine University of Yamanashi  Yamanashi Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masashi","family":"Ichijo","sequence":"additional","affiliation":[{"name":"Department of Diabetes and Endocrinology, Graduate School of Interdisciplinary Research, Faculty of Medicine University of Yamanashi  Yamanashi Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tetsuro","family":"Kobayashi","sequence":"additional","affiliation":[{"name":"Department of Endocrinology and Metabolism Toranomon Hospital  Tokyo Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2863-4561","authenticated-orcid":false,"given":"Kyoichiro","family":"Tsuchiya","sequence":"additional","affiliation":[{"name":"Department of Diabetes and Endocrinology, Graduate School of Interdisciplinary Research, Faculty of Medicine University of Yamanashi  Yamanashi Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2026,8,4]]},"reference":[{"key":"e_1_2_8_2_1","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1111\/dme.12081","article-title":"The multiple origins of type 1 diabetes","volume":"30","author":"Pugliese A","year":"2013","journal-title":"Diabet Med"},{"key":"e_1_2_8_3_1","doi-asserted-by":"crossref","first-page":"828","DOI":"10.1007\/s00125-006-0213-8","article-title":"Type 1 diabetes in Japan","volume":"49","author":"Kawasaki E","year":"2006","journal-title":"Diabetologia"},{"key":"e_1_2_8_4_1","doi-asserted-by":"crossref","first-page":"780","DOI":"10.2337\/diacare.16.5.780","article-title":"Immunogenetic and clinical characterization of slowly progressive IDDM","volume":"16","author":"Kobayashi T","year":"1993","journal-title":"Diabetes Care"},{"key":"e_1_2_8_5_1","doi-asserted-by":"crossref","first-page":"2115","DOI":"10.1210\/jc.2007-2267","article-title":"Insulin intervention in slowly progressive insulin\u2010dependent (type 1) diabetes mellitus","volume":"93","author":"Maruyama T","year":"2008","journal-title":"J Clin Endocrinol Metab"},{"key":"e_1_2_8_6_1","first-page":"807","article-title":"Statement concerning Management of Slowly Progressive Insulin\u2010dependent Diabetes Mellitus (probable)","volume":"66","author":"Shimada A","year":"2023","journal-title":"J Nihon Rinsho Denshi Kenbikyo Gakkai\u2010shi"},{"key":"e_1_2_8_7_1","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1111\/jdi.14121","article-title":"New diagnostic criteria (2023) for slowly progressive type 1 diabetes (SPIDDM): Report from committee on type 1 diabetes of the Japan diabetes society (English version)","volume":"15","author":"Shimada A","year":"2024","journal-title":"J Diabetes Investig"},{"key":"e_1_2_8_8_1","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s13340-023-00679-1","article-title":"New diagnostic criteria (2023) for slowly progressive type 1 diabetes (SPIDDM): Report from committee on type 1 diabetes in Japan diabetes society (English version)","volume":"15","author":"Shimada A","year":"2024","journal-title":"Diabetol Int"},{"key":"e_1_2_8_9_1","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1016\/j.clim.2010.10.007","article-title":"Differences in the humoral autoreactivity to zinc transporter 8 between childhood\u2010 and adult\u2010onset type 1 diabetes in Japanese patients","volume":"138","author":"Kawasaki E","year":"2011","journal-title":"Clin Immunol"},{"key":"e_1_2_8_10_1","doi-asserted-by":"crossref","first-page":"227","DOI":"10.4239\/wjd.v4.i5.227","article-title":"Sequential elevation of autoantibodies to thyroglobulin and glutamic acid decarboxylase in type 1 diabetes","volume":"4","author":"Kawasaki E","year":"2013","journal-title":"World J Diabetes"},{"key":"e_1_2_8_11_1","doi-asserted-by":"crossref","DOI":"10.3390\/ijms241210012","article-title":"Anti\u2010islet autoantibodies in type 1 diabetes","volume":"24","author":"Kawasaki E","year":"2023","journal-title":"Int J Mol Sci"},{"key":"e_1_2_8_12_1","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1016\/j.cell.2013.04.003","article-title":"The long and short of microRNA","volume":"153","author":"Yates LA","year":"2013","journal-title":"Cell"},{"key":"e_1_2_8_13_1","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1111\/cei.12834","article-title":"Altered regulatory T\u00a0cell phenotype in latent autoimmune diabetes of the adults (LADA)","volume":"186","author":"Radenkovic M","year":"2016","journal-title":"Clin Exp Immunol"},{"key":"e_1_2_8_14_1","doi-asserted-by":"crossref","first-page":"831","DOI":"10.1038\/nrg2455","article-title":"Biological principles of microRNA\u2010mediated regulation: Shared themes amid diversity","volume":"9","author":"Flynt AS","year":"2008","journal-title":"Nat Rev Genet"},{"key":"e_1_2_8_15_1","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1016\/j.ymeth.2010.01.032","article-title":"Analysis of circulating microRNA biomarkers in plasma and serum using quantitative reverse transcription\u2010PCR (qRT\u2010PCR)","volume":"50","author":"Kroh EM","year":"2010","journal-title":"Methods"},{"key":"e_1_2_8_16_1","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.bbrc.2009.09.061","article-title":"MicroRNA isolation and stability in stored RNA samples","volume":"390","author":"Mraz M","year":"2009","journal-title":"Biochem Biophys Res Commun"},{"key":"e_1_2_8_17_1","doi-asserted-by":"crossref","first-page":"1791","DOI":"10.1080\/15476286.2017.1367888","article-title":"Sources to variability in circulating human miRNA signatures","volume":"14","author":"Keller A","year":"2017","journal-title":"RNA Biol"},{"key":"e_1_2_8_18_1","doi-asserted-by":"crossref","first-page":"810","DOI":"10.1161\/CIRCRESAHA.110.226357","article-title":"Plasma microRNA profiling reveals loss of endothelial miR\u2010126 and other microRNAs in type 2 diabetes","volume":"107","author":"Zampetaki A","year":"2010","journal-title":"Circ Res"},{"key":"e_1_2_8_19_1","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1002\/dmrr.2719","article-title":"MicroRNAs as regulators of beta\u2010cell function and dysfunction","volume":"32","author":"Osmai M","year":"2016","journal-title":"Diabetes Metab Res Rev"},{"key":"e_1_2_8_20_1","doi-asserted-by":"crossref","first-page":"31479","DOI":"10.1038\/srep31479","article-title":"Pancreas\u2010enriched miRNAs are altered in the circulation of subjects with diabetes: A pilot cross\u2010sectional study","volume":"6","author":"Seyhan AA","year":"2016","journal-title":"Sci Rep"},{"key":"e_1_2_8_21_1","article-title":"Circulating levels of microRNA from children with newly diagnosed type 1 diabetes and healthy controls: Evidence that miR\u201025 associates to residual beta\u2010cell function and glycaemic control during disease progression","volume":"2012","author":"Nielsen LB","year":"2012","journal-title":"Exp Diabetes Res"},{"key":"e_1_2_8_22_1","doi-asserted-by":"crossref","DOI":"10.1038\/s41572-022-00390-6","article-title":"Adult\u2010onset autoimmune diabetes","volume":"8","author":"Buzzetti R","year":"2022","journal-title":"Nat Rev Dis Primers"},{"key":"e_1_2_8_23_1","doi-asserted-by":"crossref","first-page":"932","DOI":"10.2337\/dc06-1696","article-title":"High titer of autoantibodies to GAD identifies a specific phenotype of adult\u2010onset autoimmune diabetes","volume":"30","author":"Buzzetti R","year":"2007","journal-title":"Diabetes Care"},{"key":"e_1_2_8_24_1","doi-asserted-by":"crossref","first-page":"150","DOI":"10.2337\/diabetes.48.1.150","article-title":"Clinical and genetic characteristics of type 2 diabetes with and without GAD antibodies","volume":"48","author":"Tuomi T","year":"1999","journal-title":"Diabetes"},{"key":"e_1_2_8_25_1","doi-asserted-by":"crossref","DOI":"10.1016\/j.diabres.2023.110570","article-title":"Plasma\u2010derived exosomal miRNAs as potentially novel biomarkers for latent autoimmune diabetes in adults","volume":"197","author":"Fan W","year":"2023","journal-title":"Diabetes Res Clin Pract"},{"key":"e_1_2_8_26_1","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1530\/EJE-22-0083","article-title":"Small RNAs are differentially expressed in autoimmune and non\u2010autoimmune diabetes and controls","volume":"187","author":"S\u00f8rgjerd EP","year":"2022","journal-title":"Eur J Endocrinol"},{"key":"e_1_2_8_27_1","doi-asserted-by":"crossref","first-page":"11347","DOI":"10.1038\/s41598-019-47726-z","article-title":"Transcriptome profiling of microRNAs associated with latent autoimmune diabetes in adults (LADA)","volume":"9","author":"Yu K","year":"2019","journal-title":"Sci Rep"},{"key":"e_1_2_8_28_1","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1007\/s00592-020-01591-9","article-title":"microRNA\u2010143\u20103p contributes to inflammatory reactions by targeting FOSL2 in PBMCs from patients with autoimmune diabetes mellitus","volume":"58","author":"Pan S","year":"2021","journal-title":"Acta Diabetol"},{"key":"e_1_2_8_29_1","article-title":"Decreased serum microRNA\u201021, microRNA\u201025, microRNA\u2010146a, and microRNA\u2010181a in autoimmune diabetes: Potential biomarkers for diagnosis and possible involvement in pathogenesis","volume":"2019","author":"Liu Y","year":"2019","journal-title":"Int J Endocrinol"},{"key":"e_1_2_8_30_1","doi-asserted-by":"crossref","first-page":"2513","DOI":"10.1007\/s00125-009-1539-9","article-title":"Differential association of HLA with three subtypes of type 1 diabetes: Fulminant, slowly progressive and acute\u2010onset","volume":"52","author":"Kawabata Y","year":"2009","journal-title":"Diabetologia"},{"key":"e_1_2_8_31_1","doi-asserted-by":"crossref","first-page":"1438","DOI":"10.2337\/dc25-0579","article-title":"Rapid and slow progressors toward \u03b2\u2010cell depletion and their predictors in type 1 diabetes: Prospective longitudinal study in Japanese type 1 diabetes (TIDE\u2010J)","volume":"48","author":"Noso S","year":"2025","journal-title":"Diabetes Care"},{"key":"e_1_2_8_32_1","doi-asserted-by":"crossref","first-page":"773","DOI":"10.1530\/EC-17-0248","article-title":"MicroRNA expression profiles and type 1 diabetes mellitus: Systematic review and bioinformatic analysis","volume":"6","author":"Assmann TS","year":"2017","journal-title":"Endocr Connect"},{"key":"e_1_2_8_33_1","doi-asserted-by":"crossref","DOI":"10.1016\/j.diabres.2024.111799","article-title":"High glutamic acid decarboxylase antibody titers may be associated with a decline in \u03b2\u2010cell function over time and future insulin deficiency in latent autoimmune diabetes in adults","volume":"215","author":"Haisa A","year":"2024","journal-title":"Diabetes Res Clin Pract"},{"key":"e_1_2_8_34_1","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1210\/jc.2009-1733","article-title":"Autoantibodies to insulin, insulinoma\u2010associated antigen\u20102, and zinc transporter 8 improve the prediction of early insulin requirement in adult\u2010onset autoimmune diabetes","volume":"95","author":"Kawasaki E","year":"2010","journal-title":"J Clin Endocrinol Metab"},{"key":"e_1_2_8_35_1","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1007\/s13340-015-0211-5","article-title":"Predictive value of titer of GAD antibodies for further progression of beta cell dysfunction in slowly progressive insulin\u2010dependent (type 1) diabetes (SPIDDM)","volume":"7","author":"Tanaka S","year":"2016","journal-title":"Diabetol Int"},{"key":"e_1_2_8_36_1","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/S0168-8227(97)01377-6","article-title":"Combined measurements of GAD65 and ICA512 antibodies in acute onset and slowly progressive IDDM","volume":"35","author":"Yamada K","year":"1997","journal-title":"Diabetes Res Clin Pract"},{"key":"e_1_2_8_37_1","doi-asserted-by":"crossref","first-page":"730","DOI":"10.1046\/j.1464-5491.2002.00646.x","article-title":"Antibodies to GAD in Japanese patients classified as type 2 diabetes at diagnosis. High titre of GAD ab is a predictive marker for early insulin treatment\u2010\u2010report of west Japan (Kyushu, Yamaguchi, Osaka) study for GAD ab(+) diabetes","volume":"19","author":"Takino H","year":"2002","journal-title":"Diabet Med"},{"key":"e_1_2_8_38_1","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1007\/s13340-014-0179-6","article-title":"Clinical features of slowly progressive type 1 (insulin\u2010dependent) diabetes mellitus: A comparative study based on degree of obesity at diagnosis of diabetes","volume":"6","author":"Hoshina S","year":"2015","journal-title":"Diabetol Int"},{"key":"e_1_2_8_39_1","doi-asserted-by":"crossref","first-page":"926","DOI":"10.2337\/diab.45.7.926","article-title":"Prediction of type I diabetes in first\u2010degree relatives using a combination of insulin, GAD, and ICA512bdc\/IA\u20102 autoantibodies","volume":"45","author":"Verge CF","year":"1996","journal-title":"Diabetes"},{"key":"e_1_2_8_40_1","doi-asserted-by":"crossref","first-page":"2435","DOI":"10.2337\/dc11-0981","article-title":"A longitudinal study of GAD65 and ICA512 autoantibodies during the progression to type 1 diabetes in diabetes prevention trial\u2010type 1 (DPT\u20101) participants","volume":"34","author":"Sosenko JM","year":"2011","journal-title":"Diabetes Care"},{"key":"e_1_2_8_41_1","doi-asserted-by":"crossref","first-page":"3636","DOI":"10.2337\/db13-0300","article-title":"Patterns of \u03b2\u2010cell autoantibody appearance and genetic associations during the first years of life","volume":"62","author":"Ilonen J","year":"2013","journal-title":"Diabetes"},{"key":"e_1_2_8_42_1","doi-asserted-by":"crossref","first-page":"1409","DOI":"10.1007\/s00125-017-4294-3","article-title":"Association of serum microRNAs with islet autoimmunity, disease progression and metabolic impairment in relatives at risk of type 1 diabetes","volume":"60","author":"Snowhite IV","year":"2017","journal-title":"Diabetologia"},{"key":"e_1_2_8_43_1","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/j.ebiom.2019.11.016","article-title":"Combined identification of three miRNAs in serum as effective diagnostic biomarkers for HNSCC","volume":"50","author":"Liu C","year":"2019","journal-title":"EBioMedicine"},{"key":"e_1_2_8_44_1","doi-asserted-by":"crossref","first-page":"237","DOI":"10.3389\/fgene.2020.00237","article-title":"Combination of four serum Exosomal MiRNAs as novel diagnostic biomarkers for early\u2010stage gastric cancer","volume":"11","author":"Tang S","year":"2020","journal-title":"Front Genet"},{"key":"e_1_2_8_45_1","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1111\/cas.12880","article-title":"Novel combination of serum microRNA for detecting breast cancer in the early stage","volume":"107","author":"Shimomura A","year":"2016","journal-title":"Cancer Sci"},{"key":"e_1_2_8_46_1","doi-asserted-by":"crossref","first-page":"1124","DOI":"10.1007\/s00125-018-4559-5","article-title":"Beta cell extracellular vesicle miR\u201021\u20105p cargo is increased in response to inflammatory cytokines and serves as a biomarker of type 1 diabetes","volume":"61","author":"Lakhter AJ","year":"2018","journal-title":"Diabetologia"},{"key":"e_1_2_8_47_1","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1196\/annals.1337.014","article-title":"Is type 1 diabetes in the Japanese population the same as among Caucasians?","volume":"1037","author":"Kawasaki E","year":"2004","journal-title":"Ann N Y Acad Sci"},{"key":"e_1_2_8_48_1","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2016-011144","article-title":"Capillary blood islet autoantibody screening for identifying pre\u2010type 1 diabetes in the general population: Design and initial results of the Fr1da study","volume":"6","author":"Raab J","year":"2016","journal-title":"BMJ Open"}],"container-title":["Journal of Diabetes Investigation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/jdi.70402","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/full-xml\/10.1111\/jdi.70402","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/jdi.70402","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,4]],"date-time":"2026-08-04T10:27:56Z","timestamp":1785839276000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/jdi.70402"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8,4]]},"references-count":47,"alternative-id":["10.1111\/jdi.70402"],"URL":"https:\/\/doi.org\/10.1111\/jdi.70402","archive":["Portico"],"relation":{},"ISSN":["2040-1116","2040-1124"],"issn-type":[{"value":"2040-1116","type":"print"},{"value":"2040-1124","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,8,4]]},"assertion":[{"value":"2026-03-10","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2026-07-14","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2026-08-04","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}],"article-number":"jdi.70402"}}